Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZILRETTA for Adhesive Capsulitis of the Shoulder
NCT04831255Phase 1Terminated
- Sponsor
- University of Virginia
- Start
- Jun 2019
- Primary completion
- Aug 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of triamcinolone acetonide in adhesive capsulitis of the shoulder (AC), sponsored by University of Virginia. Primary endpoint: Visual Analog Scale Score at 6 months. Started Jun 2019; status: terminated.
02
Drugs
triamcinolone acetonide
03
Conditions
adhesive capsulitis of the shoulder (AC)
Beyond the preview
Go deeper on NCT04831255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04831255.